Puneet K C Sahota1, William C Knowler, Helen C Looker. 1. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona 85014, USA. singhp@msnotes.wustl.edu
Abstract
OBJECTIVE: American Indians have a high prevalence of diabetes and its complications, and so it may be clinically important to identify psychiatric risk factors for the development of diabetes and its complications in this population. The objectives of this cross-sectional study were (1) to determine whether depression and diabetes are associated in the Pima Indians and (2) to determine if depression is associated with variables indicating risk for development of diabetes or diabetic complications. METHOD: Adults (aged >or= 18 years) who attended research examinations in the Gila River Indian Community in Arizona from July 2003 through January 2007 were included. A sample of 2902 individuals (1121 with diabetes, 1781 without diabetes) was evaluated with the depression module of the Patient Health Questionnaire (DSM-IV criteria), physical examination, and laboratory tests. RESULTS: The prevalence of depression was slightly, but not significantly, higher among participants with diabetes than those without diabetes (12.8% vs. 9.4%, p = .053). Among participants with diabetes, mean glycosylated hemoglobin levels were significantly higher among depressed individuals than among those who were not depressed (9.0% vs. 8.4%, p = .02), even when controlling for age, sex, duration of diabetes, and body mass index (p = .03). In participants without diabetes, mean glycosylated hemoglobin levels were similar among depressed and nondepressed participants (5.4% vs. 5.4%, p = .24). CONCLUSION: Overall, participants with diabetes had a slightly, but not significantly, higher prevalence of depression than those without diabetes. Among those with diabetes, depression was associated with worse glycemic control. Treatment of depression in Pima Indians with diabetes may improve glycemic control and thereby reduce the risk of diabetic complications.
OBJECTIVE: American Indians have a high prevalence of diabetes and its complications, and so it may be clinically important to identify psychiatric risk factors for the development of diabetes and its complications in this population. The objectives of this cross-sectional study were (1) to determine whether depression and diabetes are associated in the Pima Indians and (2) to determine if depression is associated with variables indicating risk for development of diabetes or diabetic complications. METHOD: Adults (aged >or= 18 years) who attended research examinations in the Gila River Indian Community in Arizona from July 2003 through January 2007 were included. A sample of 2902 individuals (1121 with diabetes, 1781 without diabetes) was evaluated with the depression module of the Patient Health Questionnaire (DSM-IV criteria), physical examination, and laboratory tests. RESULTS: The prevalence of depression was slightly, but not significantly, higher among participants with diabetes than those without diabetes (12.8% vs. 9.4%, p = .053). Among participants with diabetes, mean glycosylated hemoglobin levels were significantly higher among depressed individuals than among those who were not depressed (9.0% vs. 8.4%, p = .02), even when controlling for age, sex, duration of diabetes, and body mass index (p = .03). In participants without diabetes, mean glycosylated hemoglobin levels were similar among depressed and nondepressed participants (5.4% vs. 5.4%, p = .24). CONCLUSION: Overall, participants with diabetes had a slightly, but not significantly, higher prevalence of depression than those without diabetes. Among those with diabetes, depression was associated with worse glycemic control. Treatment of depression in Pima Indians with diabetes may improve glycemic control and thereby reduce the risk of diabetic complications.
Authors: Richard R Rubin; William C Knowler; Yong Ma; David G Marrero; Sharon L Edelstein; Elizabeth A Walker; Sanford A Garfield; Edwin B Fisher Journal: Diabetes Care Date: 2005-04 Impact factor: 19.112
Authors: Ronny A Bell; Shannon L Smith; Thomas A Arcury; Beverly M Snively; Jeanette M Stafford; Sara A Quandt Journal: Diabetes Care Date: 2005-04 Impact factor: 19.112
Authors: Mercedes R Carnethon; Leslie S Kinder; Joan M Fair; Randall S Stafford; Stephen P Fortmann Journal: Am J Epidemiol Date: 2003-09-01 Impact factor: 4.897
Authors: John W Williams; Wayne Katon; Elizabeth H B Lin; Polly H Nöel; Jason Worchel; John Cornell; Linda Harpole; Bridget A Fultz; Enid Hunkeler; Virginia S Mika; Jürgen Unützer Journal: Ann Intern Med Date: 2004-06-15 Impact factor: 25.391
Authors: Wayne J Katon; Michael Von Korff; Elizabeth H B Lin; Greg Simon; Evette Ludman; Joan Russo; Paul Ciechanowski; Edward Walker; Terry Bush Journal: Arch Gen Psychiatry Date: 2004-10
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang Journal: JAMA Date: 2003-06-18 Impact factor: 56.272
Authors: Melissa L Walls; Benjamin D Aronson; Garrett V Soper; Michelle D Johnson-Jennings Journal: Diabetes Educ Date: 2014-02-21 Impact factor: 2.140
Authors: Benjamin D Aronson; Michelle Johnson-Jennings; Margarette L Kading; Reid C Smith; Melissa L Walls Journal: Am Indian Alsk Native Ment Health Res Date: 2016
Authors: Darren Calhoun; Janette Beals; Elizabeth A Carter; Mihriye Mete; Thomas K Welty; Richard R Fabsitz; Elisa T Lee; Barbara V Howard Journal: J Diabetes Complications Date: 2009-05-19 Impact factor: 2.852
Authors: Annelle B Primm; Melba J T Vasquez; Robert A Mays; Doreleena Sammons-Posey; Lela R McKnight-Eily; Letitia R Presley-Cantrell; Lisa C McGuire; Daniel P Chapman; Geraldine S Perry Journal: Prev Chronic Dis Date: 2009-12-15 Impact factor: 2.830